It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)—according to a new Nature Neuroscience study from researchers at Yale School of Medicine (YSM).
This article was originally published on MedicalXpress.com